Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

U.S. Government Orders 100 Million More Doses of Moderna's Coronavirus Vaccine

By Eric Volkman - Dec 11, 2020 at 7:40PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The new order doubles the country's original commitment.

The pandemic-ravaged U.S. is set to receive an additional 100 million doses of Moderna's ( MRNA 0.37% ) coronavirus vaccine, the company announced after market hours on Friday. The government has exercised an option it held with Moderna to purchase that number of doses. This doubles the country's original commitment of 100 million.

Moderna's mRNA-1273 coronavirus vaccine candidate has not yet been approved by the Food and Drug Administration. The company has filed for emergency use authorization (EUA), however. Given the very high efficacy the vaccine has shown in late-stage testing, it's widely expected to receive that green light shortly.

Child getting an injection from a medical professional.

Image source: Getty Images.

When and if that EUA is granted, Moderna said it's prepared to deliver 20 million doses under the initial 100 million commitment by the end of this month. The full balance will come in Q1 of next year. The just-optioned 100 million are to be delivered in the following quarter. 

"Securing another 100 million doses from Moderna by June 2021 further expands our supply of doses across the Operation Warp Speed portfolio of vaccines," Health and Human Services Secretary Alex Azar said of the government-supported drug and vaccine development program.

"This new federal purchase can give Americans even greater confidence we will have enough supply to vaccinate all Americans who want it by the second quarter of 2021," Azar added.

In total, Moderna said it currently has commitments to supply over 390 million doses. Other potential recipients include the countries of the EU, at 80 million; Japan, with 50 million; and Canada, at 40 million. The U.S., meanwhile, still holds an option to obtain 300 million more.

 
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Moderna, Inc. Stock Quote
Moderna, Inc.
MRNA
$283.40 (0.37%) $1.05

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
652%
 
S&P 500 Returns
142%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/08/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.